TRICARE, the government health care program for civilian family members of active military personnel, has announced that it will remove the antacid medication Nexium from its formulary drug listing beginning June 28th. After that date, the proton pump inhibitor will no longer be available in military pharmacies and clinics.
As knowledge about the problems with the hernia mesh becomes more widespread, an increasing number of patients facing hernia surgery are doing their own due diligence and asking their surgeons about different solutions. The fact is that there are alternatives to the hernia mesh. Why aren't these alternatives more widely known?
Two non-profit watchdog organizations – Beyond Pesticides and the Organic Consumers Association – filed a lawsuit against agribusiness giant Monsanto last month, alleging that the company has deliberately placed misleading and false information on the packaging of its flagship product, Roundup. The plaintiffs are demanding a trial before a jury.
Holding Them Accountable: FINRA Takes Action Against Brokers For Misconduct, Fines Brokerage Firm for Lack of Oversight
Last week, two securities brokers found themselves out of jobs and exiled from their profession after they engaged in improper and unauthorized trading activities. A third broker has been issued a “disciplinary complaint” after making an unsuitable recommendation to his clients. Additionally, a New Jersey brokerage firm has been ordered to pay a fine in the amount of $325,000 for failure to supervise the activities of its sales people.
DuPont's Priorities: $860,000 for Blood Testing, Compared to $15 Million for Lawyers and Administrators
A plaintiffs' attorney who represented claimants in a class action lawsuit against chemical giant DuPont says the company has failed to honor the terms of the 2004 settlement, requiring them to test everyone who suffered exposure to the chemical C8.
As the number of Xarelto lawsuits passes the 11,000 mark and bellwether trials get underway, drugmakers Bayer and Johnson & Johnson have filed a motion in Philadelphia to compel the court to reveal information on whether or not plaintiff cases have been funded by third parties.
So far, the month of April has been promising in the field of research on treatments and prevention of retinopathy of prematurity (ROP), a condition that occurs in premature infants that can lead to permanent blindness.
The Monsanto Empire Strikes Back: Defending Glyphosate in the Face of Evidence of its Carcinogenicity
In 2015, the International Agency for Research on Cancer released its findings indicating that glyphosate, the active chemical ingredient in Monsanto's herbicide, Roundup, was “a likely carcinogen.” Since then, Monsanto, in a battle to protect its considerable profits as well as control over the world's seeds, has launched an all-out war aimed at discrediting those findings.
Pharmaceutical Industry Lobbyist Requests to be Removed From List of Defendants in Talcum Powder Trials
Defendants in current trials over the link between talcum powder and ovarian cancer include Johnson & Johnson, manufacturer of the most popular baby powder, and Imerys Talc America, supplier of the talc used in the product. However, there has been a third named defendant: the Personal Care Products Council (PCPC). Based in Washington D.C., the PCPC is a trade association and lobbying group, representing over 600 companies that manufacture and distribute personal care products.